Lucie Ellis-TaittExecutive Director - In Vivo at CitelineSpeaker
Lucie Ellis-Taitt has been reporting on the biopharma and medtech industries for more than a decade. As executive editor for In Vivo, she is responsible for setting the publication’s agenda, managing a team of experienced journalists and reporting on the most important topics for In Vivo’s audience of industry leaders.
In Vivo is the premiere resource for life sciences business strategy, covering the biopharma, medtech and diagnostics industries in one authoritative package. With a unique understanding of the forces shaping global health care, In Vivo delivers the ‘so what?’ underpinning industry events, helping readers make proactive rather than reactive business decisions, broker deals with confidence, and identify opportunities.